Your browser doesn't support javascript.
loading
Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of Covid-19 death
Laszlo Szekely; Bela Bozoky; Matyas Bendek; Masih Ostad; Pablo Lavignasse; Lars Haag; Jieyu Wu; Xu Jing; Soham Gupta; Elisa Saccon; Anders Sonnerborg; Yihai Cao; Mikael Bjornstedt; Attila Szakos.
Affiliation
  • Laszlo Szekely; Karolinska Institutet
  • Bela Bozoky; Karolinska University Hospital
  • Matyas Bendek; Karolinska University Hospital
  • Masih Ostad; Karolinska University Hospital
  • Pablo Lavignasse; Karolinska University Hospital
  • Lars Haag; Karolinska Institutet
  • Jieyu Wu; Karolinska Institutet
  • Xu Jing; Karolinska Institutet
  • Soham Gupta; Karolinska Institutet
  • Elisa Saccon; Karolinska Institutet
  • Anders Sonnerborg; Karolinska Institutet
  • Yihai Cao; Karolinska Institutet
  • Mikael Bjornstedt; Karolinska Institutet
  • Attila Szakos; Karolinska University Hospital
Preprint in English | bioRxiv | ID: ppbiorxiv-424172
Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article
ABSTRACT
Most Covid-19 victims are old and die from unrelated causes. Here we present twelve complete autopsies, including two rapid autopsies of young patients where the cause of death was Covid-19 ARDS. The main virus induced pathology was in the lung parenchyma and not in the airways. Most coagulation events occurred in the intra-alveolar and not in the intra-vascular space and the few thrombi were mainly composed of aggregated thrombocytes. The dominant inflammatory response was the massive accumulation of CD163+ macrophages and the disappearance of T killer, NK and B-cells. The virus was replicating in the pneumocytes and macrophages but not in bronchial epithelium, endothel, pericytes or stromal cells. The lung consolidations were produced by a massive regenerative response, stromal and epithelial proliferation and neovascularization. We suggest that thrombocyte aggregation inhibition, angiogenesis inhibition and general proliferation inhibition may have a roll in the treatment of advanced Covid-19 ARDS.
License
cc_no
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2020 Document type: Preprint
...